Deutsche Bank Aktiengesellschaft restated their buy rating on shares of Johnson Matthey (LON:JMAT – Free Report) in a report issued on Monday morning, MarketBeat.com reports. The firm currently has a GBX 2,400 ($30.45) target price on the stock.
Other research analysts also recently issued reports about the company. Jefferies Financial Group restated a buy rating and set a GBX 2,100 ($26.64) price objective on shares of Johnson Matthey in a report on Wednesday, March 20th. Berenberg Bank restated a hold rating and set a GBX 1,800 ($22.83) price objective on shares of Johnson Matthey in a report on Tuesday, June 11th. Finally, Numis Securities restated a buy rating and set a GBX 2,200 ($27.91) price objective on shares of Johnson Matthey in a report on Wednesday, March 20th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Johnson Matthey presently has a consensus rating of Moderate Buy and an average target price of GBX 1,993.33 ($25.29).
Read Our Latest Research Report on Johnson Matthey
Johnson Matthey Trading Down 0.1 %
Johnson Matthey Increases Dividend
The business also recently announced a dividend, which will be paid on Tuesday, August 6th. Shareholders of record on Thursday, June 6th will be given a dividend of GBX 55 ($0.70) per share. This represents a yield of 3.04%. The ex-dividend date is Thursday, June 6th. This is a boost from Johnson Matthey’s previous dividend of $22.00. Johnson Matthey’s dividend payout ratio (DPR) is 13,050.85%.
Insider Transactions at Johnson Matthey
In other news, insider Liam Condon purchased 24 shares of the stock in a transaction on Wednesday, April 17th. The stock was bought at an average price of GBX 1,767 ($22.42) per share, with a total value of £424.08 ($537.97). Insiders acquired 66 shares of company stock valued at $113,214 in the last quarter. 0.57% of the stock is currently owned by corporate insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Further Reading
- Five stocks we like better than Johnson Matthey
- Why Are Stock Sectors Important to Successful Investing?
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- What is Insider Trading? What You Can Learn from Insider Trading
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Why is the Ex-Dividend Date Significant to Investors?
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.